We found the expression levels of dopamine receptor D2 are relatively higher in the lesion of dermatitis patients compared to control subjects and future study remains to determine which type of immune cells are responsible for the expression of dopamine receptor in the dermatitis lesion (Figure 1C and Table S1). The gene discussed is DRD2; the disease is skin disorder.